特地唑胺对利奈唑胺不敏感革兰阳性球菌的体外抗菌活性研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

南京大学中国医院改革发展研究院课题;南京鼓楼医院医学发展医疗救助基金会资助项目(NDYG2022048)


In vitro antibacterial activity of tedizolid against linezolid -resistant G ram-positive cocci
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:目的检测利奈唑胺不敏感革兰阳性球菌对新型噫唑烷酮类抗菌药物特地唑胺的敏感性,并探讨特地唑胺不敏感菌株 的耐药机制。方法收集临床分离非重复革兰阳性球菌 170株,包括利奈唑胺耐药头状葡萄球菌46株、利奈唑胺敏感头状葡 萄球菌19株、利奈唑胺不敏感肠球菌55株、利奈唑胺敏感肠球菌12株、甲氧西林耐药金黄色葡萄球菌19株、甲氧西林敏感 金黄色葡萄球菌18株、利奈唑胺耐药金黄色葡萄球菌1株。采用微量肉汤稀释法检测所有菌株对特地唑胺和利奈唑胺的最 小抑茵浓度(MIC),并比较两种药物的抗菌活性。采用PCR结合Sanger测序技术分析特地唑胺不敏感革兰阳性球茵fr、optrA 基因携带情况及23S rRNA V区突变。结果利奈唑胺耐药头状葡萄球茵(MICg0>256 μg/mL)对特地唑胺的MIC 值为4~ 32 ug/mL; 利奈唑胺不敏感肠球菌(MIC值4~ 16 μg/mL)中,特地唑胺的敏感率为10.% ,其MIC值为0.5~2 μg/mL;1株利奈 唑胺耐药金黄色葡萄球菌对特地唑胺敏感,MIC值为0.5μg/mL。特地唑胺对利奈唑胺敏感的金黄色葡萄球茵和肠球茵的 MIC值均为0.5 μg/mL,对利奈唑胺敏感头状葡萄球菌的MIC值为0. 125 μg/mL。耐药基因分析显示,特地唑胺耐药头状葡萄 球菌gfr基因携带率为87.0%(40/46) ,23S rRNA V区G2576T的突变率为100% ;特地唑胺不敏感肠球菌optrA 基因携带率为 85.7% (42/49) ,显著高于特地唑胺敏感株的22.2%( P<0.001);1株利奈唑胺耐药特地唑胺敏感的金黄色葡萄球菌携帶cfr基 因。结论对于利奈唑胺不敏感的革兰阳性球菌,特地唑胺的抗茵活性是利奈唑胺的8~32倍,其耐药机制可能与携带optrA 基因及23S rRNA V区G2576T突变有关。

    Abstract:

    Abstract: Objective To investigate the susceptibilities of linezolid-resistant Gram-positive cocci to tedizolid, a novel oxazolidinoneantibiotic, and the drug resistance mechanism of tedizolid-resist ant isolates. Methods A total of 170 clinical isolates of non-repetitive Gram-positive cocei were collected ,including 46 linezolid-resistant Staphylococcus capitis ( LRSC), 19 linezolid-susceptible Staphylococcus capitis ( LSSC) , 55 linezolid-resistant Enterococcus ( LRE),12 linezolid-susceptible Enterococcus ( LSE),19 methicillin-resistant Staphyloccus aureus ( MRSA), 18 methicillin-susceptible Staphyloccus aureus ( MSSA) and 1 linezolid-resistant Staphylococcus aureus (LRSA). The minimal inhibitory concentrations ( MIC) of all isolates against tedizolid and linezolid were determined by the broth dilution method,and the antibacterial activities of the two drugs were compared. The resistance genes ofr and optrA and the mutation of 23S RNA V region in the tedizolid-resistant Gram-positive cocci were detected by PCR combined with Sanger sequencing. Results The MIC of tedizolid against LRSC ( MICgo> 256 μg/mL) was 4-32 μg/mL. The sensitivity rate and MIC of tedizolid against LRE ( MIC for linezolid: 4-16 μg/mL) were 10.9% and 0. 5-2 μg/ mL, respectively. One strain of LRSA was sensitive to tedizolid,and its MIC was 0.5 μg/mL. The MICs of tedizolid against LSE and LSSC were 0.5 μg/mL and 0.125 μg/mL, respectively. Analysis of resistance genes showed that the carrying rate of cfr gene in tedizolid-resistant Staphylococcus capitis was 87.0% ( 40/46),and that the mutation rate of G2576T in 23S rRNA V region was 100%. The carrying rate of optrA gene in tedizolid-resistant Enterococci was 85.7% (42/49) ,which was signifcantly higher than that in tedizolid-susceptible strains ( 22.2%, P<0.001 ). One linezolid-resistant and tedizolid-susceptible Staphylococcus aureus stain carried the cfr gene. Conclusion The antibacterial activity of tedizolid against linezolid-resistant Gram-positive cocci is 8-32 times that of linezolid, and its resistance mechanism may be related to canying optrAgene and G2576T mutation in 23S rRNA V region.

    参考文献
    相似文献
    引证文献
引用本文

高硕,徐学静,纪玥玥,贾佳,张燕,周万青,沈瀚.特地唑胺对利奈唑胺不敏感革兰阳性球菌的体外抗菌活性研究[J].临床检验杂志,2023,41(05):335-339

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-01-07
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-09-06
  • 出版日期:
文章二维码
您是第位访问者  苏ICP备13058113号-3
苏公网安备32010202012004号
主管单位:江苏省医学会  出版单位:临床检验杂志
单位地址:江苏省南京市中央路42号  邮编:210008
电话:025-83620683 E-MAIL:lcjyzz@163.com
技术支持:北京勤云科技发展有限公司